Split History
ETFs Holding TBRA »    TBRA Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Tobira Therapeutics is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapies to treat liver disease, inflammation, fibrosis and human immunodeficiency virus (HIV). Co.'s product candidate, cenicriviroc (CVC), is an immunomodulator and dual inhibitor of CCR2 and CCR5 being evaluated for the treatment of non-alcoholic steatohepatitis (NASH), primary sclerosing cholangitis (PSC), and as an adjunctive therapy to standard of care in HIV. Co. operates in one reportable segment in the U.S. of America. CVC is an oral, once-daily, potent immunomodulator with a binding affinity. NASH is a severe type of non-alcoholic fatty liver disease. According to our TBRA split history records, TBRA has had 1 split.
TBRA split history picture
TBRA (TBRA) has 1 split in our TBRA split history database. The split for TBRA took place on May 05, 2015. This was a 1 for 9 reverse split, meaning for each 9 shares of TBRA owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 111.111111111111 share position following the split.

When a company such as TBRA conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the TBRA split history from start to finish, an original position size of 1000 shares would have turned into 111.111111111111 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into TBRA shares, starting with a $10,000 purchase of TBRA, presented on a split-history-adjusted basis factoring in the complete TBRA split history. TBRA split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 08/22/2013
End date: 11/01/2016
Start price/share: $42.30
End price/share: $42.09
Dividends collected/share: $0.00
Total return: -0.50%
Average Annual Total Return: -0.16%
Starting investment: $10,000.00
Ending investment: $9,948.93
Years: 3.20
Date Ratio
05/05/20151 for 9
TBRA is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

TCON Split History
TEAR Split History
TECH Split History
TELK Split History
TENX Split History
TEVA Split History
TFX Split History
TGTX Split History
TGX Split History
THC Split History

Altus Midstream Company (ATLM)
FS KKR Capital Corp. (FSK)
Groupon (GRPN)
XpresSpa Group, Inc. (XSPA)
Energy Focus, Inc. (EFOI)
The Cushing NextGen Infrastructure Income Fund (SZC)
Teligent, Inc. (TLGT)
Laredo Petroleum, Inc. (LPI)
Global Eagle Entertainment Inc. (ENT)
ToughBuilt Industries, Inc. (TBLT)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

TBRA Insider Buying

TBRA Split History | www.SplitHistory.com | Copyright © 2013 - 2020, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.